The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 3, 2004, Pages 205-211

  Sanderson, Kristin M ^a   Stein, John P ^a   Skinner, Donald G ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bladder cancer; Bladder neoplasm; Cystectomy; Lymph node density; Lymph node dissection; Lymph node metastasis; Lymphadenectomy; Transitional cell carcinoma

Indexed keywords

ANTIINFECTIVE AGENT;

BLADDER CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CORRELATION ANALYSIS; CYSTECTOMY; HIGH RISK POPULATION; HUMAN; ILIAC ARTERY; INFERIOR MESENTERIC ARTERY; LYMPH NODE DISSECTION; LYMPHADENOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPHADENECTOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; STATISTICAL SIGNIFICANCE;

CYSTECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 3242723269     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2004.04.030     Document Type: Conference Paper

References (46)

1. Whitmore W.F., Marshall V.F. Radical total cystectomy for cancer of the bladder 230 consecutive cases five years later. J Urol. 87:1962;853-868
2. Kerr W.S., Colby F.H. Pelvic lymph node dissection and total cystectomy in the treatment of carcinoma of the bladder. J Urol. 63:1950;842-851
3. Halstead W.S. The treatment of wounds. Johns Hopkins Hosp Rep. 2:1891;279
4. Colston J.A., Leadbetter W.F. Infiltrating carcinoma of the bladder. J Urol. 36:1936;669-689
5. Jewett H.J., Strong G.H. Infiltrating carcinoma of the bladder relation of depth of penetration of the bladder wall to incidence of local extension and metastases. J Urol. 55:1946;366-372
6. Vieweg J., Gschwend J.E., Herr H.W., et al. The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol. 161:1999;72-76
7. Vieweg J., Gschwend J.E., Herr H., et al. Pelvic lymph nodes dissection can be curative in patients with lymph node positive disease. J Urol. 161:1999;449-454
8. Stein J.P., Skinner D.G. Results with radical cystectomy for treating bladder cancer a 'reference standard' for high-grade, invasive bladder cancer. BJU. 92:2003;12-17
9. Leissner J., Ghoneim H., Abol-Enein J., et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer results of a prospective multicenter study. J Urol. 171:2004;139-144
10. Skinner D.G. Management of invasive bladder cancer a meticulous pelvic node dissection can make a difference. J Urol. 128:1982;34-36
11. Lerner S.P., Skinner D.G., Lieskovsky G., et al. The rationale for en bloc PLND for bladder cancer patients with nodal metastases long-term results. J Urol. 149:1993;758-764
12. Leadbetter W.F., Cooper J.F. Regional gland dissection for carcinoma of the bladder a technique for one-stage cystectomy, gland dissection and bilateral uretero-enterostomy. J Urol. 63:1950;242-260
13. Dretler S.P., Ragsdale B.D., Leadbetter W.F. The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer. J Urol. 109:1973;414-416
14. Wishnow K.I., Johnson D.E., Ro J., et al. Incidence, extent and location of unsuspected pelvic lymph node metastasis in patients undergoing radical cystectomy for bladder cancer. J Urol. 137:1987;408-410
15. Skinner D.G. Current state of classification and staging of bladder cancer. Cancer Res. 37:1977;2838-2842
16. Raghavan D., Quinn D., Skinner D.G., et al. Surgery and adjunctive chemotherapy for invasive bladder cancer. Surg Oncol. 11:2002;55-63
17. Skinner D.C., Daniels J.R., Russell C.A., et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer a prospective comparative trial. J Urol. 145:1991;459-467
18. Frieha F.S., Reese J., Torti F. A randomized trial of radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol. 155:1996;1241-1245
19. Mills R.D., Turner W.H., Fleischmann R., et al. Pelvic lymph node metastasis from bladder cancer outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol. 166:2001;19-23
20. Madersbacher S., Hochreiter W., Burkhard F., et al. Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol. 21:2003;690-696
21. Konety B.R., Joslyn S.A., O'Donnell M.A. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer analysis of data from the surveillance, epidemiology and end results program data base. J Urol. 169:2003;946-950
22. Herr H.W. Surgical factors in bladder cancer more (nodes) + more (pathology) = less (mortality). BJU. 92:2003;187-188
23. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer long-term results in 1,054 patients. J Clin Oncol. 19:2001;666-675
24. Paik M.L., Scolieri M.J., Brown S.L., et al. Limitations of CT in staging invasive bladder cancer before radical cystectomy. J Urol. 163:2000;1693
25. Persad R., Kabala J., Gillatt D., et al. MRI in the staging of bladder cancer. Br J Urol. 71:1993;566-573
26. 18F]-2-Deoxy-D-Glucose. Eur Urol. 36:1999;582-587
27. Bachor R., Kotzerke J., Reske S.N., et al. Lymph node staging of bladder neck carcinoma with positron emission tomography in patients with bladder cancer. Eur J Num Med. 24:1997;615-620
28. Nathanson D.S. Insights into the mechanisms of lymph node metastsis. Cancer. 98:2003;413-422
29. Perrott R.E., Reintgen D.S., Fenske N.A. Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma. J Am Acad Derm. 49:2003;567-588
30. Sherif A., De La Torre M., Malmstrom P.U., et al. Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J Urol. 166:2001;812-815
31. Liedberg F., Chebil G., Davidsson T., et al. Bladder cancer and the sentinel node concept. Aktuel Urol. 34:2003;115-118
32. Stein J.P., Cai J., Groshen S., et al. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy the concept of lymph node density. J Urol. 170:2003;35-41
33. Herr H.W., Bochner B.H., Dalbagni G., et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol. 167:2002;1295-1999
34. Fleming I.D., Cooper J.S., Henson D.E., et al. AJCC cancer staging system manuel. 5th ed. :1997;JB Lippincott, Philadelphia
35. Herr H. Superiority of ratio based LN staging for bladder cancer. J Urol. 169:2003;943-945
36. Herr H.W., Donat S.M. Outcomes of patients with grossly node positive bladder cancer after pelvic lymph node dissection and cystectomy. J Urol. 165:2001;62-64
37. Poulsen A., Horn T., Steven K. Radical cystectomy extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol. 160:1998;2015-2019
38. Leissner J., Hohenfellner R., Thuroff J.W., et al. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder significance for staging and prognosis. BJU Int. 85:2000;817-823
39. Bochner B.H., Herr H.W., Reuter V.E. Impact of separate versus en bloc pelvic lymph node dissection on the number of nodes retrieved in cystectomy specimens. J Urol. 166:2001;2295-2296
40. Vieweg J., Gschwend J.E., Herr H., et al. Pelvic lymph nodes dissection can be curative in patients with lymph node positive disease. J Urol. 161:1999;449-454
41. Stein J.P., Skinner D.G. Results with radical cystectomy for treating bladder cancer a 'reference standard' for high-grade, invasive bladder cancer. BJU. 92:2003;12-17
42. Ghoneim M.A., El-Mekresh M.M., El-Baz M.A., et al. Radical cystectomy for carcinoma of the bladder critical evaluation of the results in 1,026 cases. J Urol. 158:1997;393-399
43. Herr H. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology. 61:2003;105-109
44. Weingartner K., Ramaswamy A., Bittinger A., et al. Anatomical basis for pelvic lymphadenectomy in prostate cancer results of an autopsy study and implications for the clinic. J Urol. 156:1996;1969-1971
45. Marshall V.F. The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J Urol. 68:1952;714-716
46. Konety B.R., Joslyn S.A. Factors influencing aggressive therapy for bladder cancer an analysis of data from the SEER program. J Urol. 170:2003;1765-1771